Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Omega-3 fatty acids for major depressive disorder during pregnancy: results from a randomized, double-blind, placebo-controlled trial.

Su KP, Huang SY, Chiu TH, Huang KC, Huang CL, Chang HC, Pariante CM.

J Clin Psychiatry. 2008 Apr;69(4):644-51.

PMID:
18370571
2.

The synchronized trial on expectant mothers with depressive symptoms by omega-3 PUFAs (SYNCHRO): Study protocol for a randomized controlled trial.

Nishi D, Su KP, Usuda K, Chiang YJ, Guu TW, Hamazaki K, Nakaya N, Sone T, Sano Y, Tachibana Y, Ito H, Isaka K, Hashimoto K, Hamazaki T, Matsuoka YJ.

BMC Psychiatry. 2016 Sep 15;16(1):321. doi: 10.1186/s12888-016-1031-2.

3.

Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial.

Carney RM, Freedland KE, Rubin EH, Rich MW, Steinmeyer BC, Harris WS.

JAMA. 2009 Oct 21;302(15):1651-7. doi: 10.1001/jama.2009.1487.

4.

Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial.

Su KP, Huang SY, Chiu CC, Shen WW.

Eur Neuropsychopharmacol. 2003 Aug;13(4):267-71. Erratum in: Eur Neuropsychopharmacol. 2004 Mar;14(2):173.

PMID:
12888186
5.

Omega-3 fatty acids and supportive psychotherapy for perinatal depression: a randomized placebo-controlled study.

Freeman MP, Davis M, Sinha P, Wisner KL, Hibbeln JR, Gelenberg AJ.

J Affect Disord. 2008 Sep;110(1-2):142-8. doi: 10.1016/j.jad.2007.12.228. Epub 2008 Feb 21.

PMID:
18206247
6.

Long-chain polyunsaturated fatty acid status during pregnancy and maternal mental health in pregnancy and the postpartum period: results from the GUSTO study.

Chong MF, Ong YL, Calder PC, Colega M, Wong JX, Tan CS, Lim AL, Fisk HL, Cai S, Pang WW, Broekman BF, Saw SM, Kwek K, Godfrey KM, Chong YS, Gluckman P, Meaney MJ, Chen H; GUSTO Study Group.

J Clin Psychiatry. 2015 Jul;76(7):e848-56. doi: 10.4088/JCP.14m09191.

PMID:
26231011
7.

Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.

Amminger GP, Schäfer MR, Papageorgiou K, Klier CM, Cotton SM, Harrigan SM, Mackinnon A, McGorry PD, Berger GE.

Arch Gen Psychiatry. 2010 Feb;67(2):146-54. doi: 10.1001/archgenpsychiatry.2009.192.

PMID:
20124114
8.

Omega-3 Fatty Acids, Depressive Symptoms, and Cognitive Performance in Patients With Coronary Artery Disease: Analyses From a Randomized, Double-Blind, Placebo-Controlled Trial.

Mazereeuw G, Herrmann N, Oh PI, Ma DW, Wang CT, Kiss A, Lanctôt KL.

J Clin Psychopharmacol. 2016 Oct;36(5):436-44. doi: 10.1097/JCP.0000000000000565.

9.

Supplementation of n-3 Polyunsaturated Fatty Acids for Major Depressive Disorder: A Randomized, Double-Blind, 12-Week, Placebo-Controlled Trial in Korea.

Park Y, Park YS, Kim SH, Oh DH, Park YC.

Ann Nutr Metab. 2015;66(2-3):141-8. doi: 10.1159/000377640. Epub 2015 Mar 24.

PMID:
25824637
10.
11.

Omega-3 supplementation from pregnancy to postpartum to prevent depressive symptoms: a randomized placebo-controlled trial.

Vaz JDS, Farias DR, Adegboye ARA, Nardi AE, Kac G.

BMC Pregnancy Childbirth. 2017 Jun 9;17(1):180. doi: 10.1186/s12884-017-1365-x.

12.

Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation.

da Silva TM, Munhoz RP, Alvarez C, Naliwaiko K, Kiss A, Andreatini R, Ferraz AC.

J Affect Disord. 2008 Dec;111(2-3):351-9. doi: 10.1016/j.jad.2008.03.008. Epub 2008 May 15.

PMID:
18485485
13.

Supportive psychotherapy for perinatal depression: preliminary data for adherence and response.

Freeman MP, Davis MF.

Depress Anxiety. 2010;27(1):39-45. doi: 10.1002/da.20596.

PMID:
19691033
14.

Omega-3 fatty acids as a treatment for perinatal depression: randomized double-blind placebo-controlled trial.

Rees AM, Austin MP, Parker GB.

Aust N Z J Psychiatry. 2008 Mar;42(3):199-205. doi: 10.1080/00048670701827267. Erratum in: Aust N Z J Psychiatry. 2008 May;42(5):438.

PMID:
18247194
15.

Is essential fatty acid status in late pregnancy predictive of post-natal depression?

Parker G, Hegarty B, Granville-Smith I, Ho J, Paterson A, Gokiert A, Hadzi-Pavlovic D.

Acta Psychiatr Scand. 2015 Feb;131(2):148-56. doi: 10.1111/acps.12321. Epub 2014 Aug 6.

PMID:
25131141
16.

A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.

Hellerstein DJ, Stewart JW, McGrath PJ, Deliyannides DA, Batchelder ST, Black SR, Withers A, O'Shea D, Chen Y.

J Clin Psychiatry. 2012 Jul;73(7):984-91. doi: 10.4088/JCP.11m07230.

PMID:
22901348
17.

Dietary supplements for preventing postnatal depression.

Miller BJ, Murray L, Beckmann MM, Kent T, Macfarlane B.

Cochrane Database Syst Rev. 2013 Oct 24;(10):CD009104. doi: 10.1002/14651858.CD009104.pub2. Review.

PMID:
24158923
18.

A randomized, double-blind, placebo-controlled study of light therapy for antepartum depression.

Wirz-Justice A, Bader A, Frisch U, Stieglitz RD, Alder J, Bitzer J, Hösli I, Jazbec S, Benedetti F, Terman M, Wisner KL, Riecher-Rössler A.

J Clin Psychiatry. 2011 Jul;72(7):986-93. doi: 10.4088/JCP.10m06188blu. Epub 2011 Apr 5.

PMID:
21535997
19.
20.

Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trial.

Brecht S, Courtecuisse C, Debieuvre C, Croenlein J, Desaiah D, Raskin J, Petit C, Demyttenaere K.

J Clin Psychiatry. 2007 Nov;68(11):1707-16.

PMID:
18052564

Supplemental Content

Support Center